RadioTransNet: Preclinical research network coordinated at the SFRO and SFPM.

Area of Science:

• Radiation Oncology
• Medical Physics
• Translational Research

Background:

• The French national cancer institute (INCa) approved the RadioTransNet program in December 2018.
• The program is a joint initiative of the French societies for radiation oncology (SFRO) and medical physics (SFPM).
• It aims to create a national, transversal structure for preclinical and translational research in radiation oncology.

Purpose of the Study:

• To establish well-defined priority areas for radiation oncology research.
• To foster collaboration between radiation oncologists, medical physicists, and academic biologists.
• To integrate fundamental radiobiology, new drug development, medical imaging, and medical physics research.

Main Methods:

• Activities are coordinated by a scientific committee.
• Research is structured around key areas: target volume definition, radiation-normal tissue interaction, combined treatments, and dose calculation.
• Four work packages address specific research objectives, including fundamental radiobiology and cost-efficiency evaluation.

Main Results:

• A national network is being developed to leverage complementary partner expertise.
• Calls for proposals will be selected for funding submission to INCa and academic associations.
• The program aims to secure resources for optimal preclinical and translational research projects.

Conclusions:

• RadioTransNet provides a structured framework for advancing radiation oncology research in France.
• The program integrates multidisciplinary expertise to address critical research questions.
• It facilitates the funding and execution of high-impact preclinical and translational studies.